Literature DB >> 19375237

Substance dependence and remission in schizophrenia: A comparison of schizophrenia and affective disorders.

Melanie E Bennett1, Alan S Bellack, Clayton H Brown, Carlo DiClemente.   

Abstract

The present study examined psychiatric functioning, substance use and consequences, and motivation to change in people with schizophrenia and affective disorders and current or remitted cocaine dependence. Data were collected as part of a naturalistic, longitudinal study examining substance use, motivation to change, and the process of change in people with schizophrenia and affective disorders who were currently dependent or in remission from cocaine dependence. We examined the following questions: (1) Do those in remission show better psychiatric functioning than those who are currently dependent? (2) How do people with schizophrenia and current cocaine dependence differ in terms of substance use and consequences from people with schizophrenia in remission and people with affective disorders and current drug dependence? (3) What internal factors and external factors are associated with changes in substance use in schizophrenia and how do these compare to those in nonpsychotic affective disorders? Results indicated that people with schizophrenia and current dependence reported higher levels of positive and negative symptoms than those in remission. Remission status was related to less use of other drugs, fewer days of drug problems, less distress from drug problems, and more lifetime drug-related consequences. Those with current dependence reported more days of drinking and drinking to intoxication, as well as higher rates of current alcohol use disorders than the remitted group. When compared to those with affective disorders and cocaine dependence, those with schizophrenia and current dependence reported fewer days of problems associated with their drug use, less distress from drug problems, and fewer recent and lifetime consequences associated with their drug use. The schizophrenia dependent group generally showed the lowest readiness to change, fewest efforts being made to change, and lowest confidence in the ability to change. Implications of these findings are discussed.

Entities:  

Mesh:

Year:  2009        PMID: 19375237      PMCID: PMC3607082          DOI: 10.1016/j.addbeh.2009.03.023

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  63 in total

Review 1.  Psychosocial approaches to dual diagnosis.

Authors:  R E Drake; K T Mueser
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

2.  Comorbid substance-use in schizophrenia: relation to positive and negative symptoms.

Authors:  A Talamo; F Centorrino; L Tondo; A Dimitri; J Hennen; R J Baldessarini
Journal:  Schizophr Res       Date:  2006-06-05       Impact factor: 4.939

Review 3.  Substance misuse, psychiatric disorder and violent and disturbed behaviour.

Authors:  M Soyka
Journal:  Br J Psychiatry       Date:  2000-04       Impact factor: 9.319

4.  Decisional balance regarding substance use among persons with schizophrenia.

Authors:  K B Carey; D M Purnine; S A Maisto; M P Carey; K L Barnes
Journal:  Community Ment Health J       Date:  1999-08

5.  Future directions in preventing relapse to substance abuse among clients with severe mental illnesses.

Authors:  Robert E Drake; Michael A Wallach; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2005-10       Impact factor: 3.084

Review 6.  Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes.

Authors:  L Dixon
Journal:  Schizophr Res       Date:  1999-03-01       Impact factor: 4.939

Review 7.  Comorbid schizophrenia and substance abuse: a review of epidemiology and course.

Authors:  Joseph Westermeyer
Journal:  Am J Addict       Date:  2006 Sep-Oct

8.  A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.

Authors:  Alan S Bellack; Melanie E Bennett; Jean S Gearon; Clayton H Brown; Ye Yang
Journal:  Arch Gen Psychiatry       Date:  2006-04

9.  Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.

Authors:  Marvin S Swartz; H Ryan Wagner; Jeffrey W Swanson; T Scott Stroup; Joseph P McEvoy; Jose M Canive; Del D Miller; Fred Reimherr; Mark McGee; Ahsan Khan; Richard Van Dorn; Robert A Rosenheck; Jeffrey A Lieberman
Journal:  J Nerv Ment Dis       Date:  2006-03       Impact factor: 2.254

10.  A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: changes in psychiatric symptoms and substance use.

Authors:  Howard C Margolese; Juan Carlos Negrete; Raymond Tempier; Kathryn Gill
Journal:  Schizophr Res       Date:  2006-02-07       Impact factor: 4.939

View more
  8 in total

1.  Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization.

Authors:  Amber L Bahorik; Christina E Newhill; Shaun M Eack
Journal:  Addiction       Date:  2013-03-28       Impact factor: 6.526

2.  N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse.

Authors:  Matthew D Puhl; Rajeev I Desai; Shunsuke Takagi; Kendall T Presti; Michelle R Doyle; Rachel J Donahue; Samantha M Landino; Jack Bergman; William A Carlezon; Joseph T Coyle
Journal:  Addict Biol       Date:  2017-11-23       Impact factor: 4.280

3.  Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders.

Authors:  Clayton H Brown; Melanie E Bennett; Lan Li; Alan S Bellack
Journal:  Addict Behav       Date:  2010-12-10       Impact factor: 3.913

4.  Patterns and Predictors of Changes in Substance Use in Individuals with Schizophrenia and Affective Disorders.

Authors:  Melanie E Bennett; Clayton H Brown; Jason Peer; Lan Li; Alan S Bellack
Journal:  J Dual Diagn       Date:  2012-02-13

5.  Impact of Family History in Persons With Dual Diagnosis.

Authors:  Camille S Wilson; Melanie E Bennett; Alan S Bellack
Journal:  J Dual Diagn       Date:  2012-11-27

6.  Lifetime trauma, subjective distress, substance use, and PTSD symptoms in people with severe mental illness: comparisons among four diagnostic groups.

Authors:  Thomas O'Hare; Margaret Sherrer
Journal:  Community Ment Health J       Date:  2013-06-29

7.  Executive Functioning in Men with Schizophrenia and Substance Use Disorders. Influence of Lifetime Suicide Attempts.

Authors:  Ana Adan; Maria Del Mar Capella; Gemma Prat; Diego A Forero; Silvia López-Vera; José Francisco Navarro
Journal:  PLoS One       Date:  2017-01-18       Impact factor: 3.240

Review 8.  Meta-Analysis on the Effect of Contingency Management for Patients with Both Psychotic Disorders and Substance Use Disorders.

Authors:  Marianne Destoop; Lise Docx; Manuel Morrens; Geert Dom
Journal:  J Clin Med       Date:  2021-02-06       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.